Dan Li, MD
Gastroenterology · Santa Clara
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Offices
- 2
Offices
2 locations · Permanente Medical Group Inc · 10,928 clinicians in this group
Looking this up.
Hospitals listed: Kaiser Foundation Hospital-Santa Clara. That is not proof they admit you there this week.
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Li’s office at (408) 851-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
California Medical Board record
Licence A93986 · Current
Licensed to practise in California · since 2006 · expires 2027-10-31 · Peking Union Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Kaiser Foundation Hospital-Santa ClaraSanta Clara, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Kaiser Permanente, which runs 41 hospitals in 3 statesPatients rate it 3 of 5 · 75% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.38, Oct 2024 – Sep 2025
See every measure and the patient survey for Kaiser Foundation Hospital-Santa Clara
Behind the star rating — Deaths: 0 better, 3 the same, 0 worse of 3 measures. Safety: 2 better, 4 the same, 0 worse of 6 measures. Readmissions: 0 better, 1 the same, 1 worse of 2 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.38 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.01 (0 to 2.09) · 181 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.61 to 1.42) | No different | Jul 2022 – Jun 2024 |
| Death rate for stroke patientsComplications and deaths | 10.5 · 312 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 3,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 910 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.48) · 1,036 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.53 (2.03 to 7.03) · 235 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.57 (0 to 3.25) · 83 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.5 (0.82 to 4.18) · 178 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.73 (3.81 to 19.64) · 74 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.31 (1.3 to 9.32) · 94 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.75 (0.22 to 3.28) · 37 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.34 (0 to 1.34) · 819 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.72 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.049 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.598 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.926 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13 · 589 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.7 · 828 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 107.6 · 27 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 642 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 7.8 · 249 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 181 cases | None | Jul 2023 – Jun 2025 |
What patients said (572 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 72% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 44% |
| "YES", patients would definitely recommend the hospital | 75% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Procedures Medicare counted
| Colonoscopy | 1-10 | None |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 1-10 | None |
Drugs they prescribed that Part D paid
$180,719
Pharmacies billed $180,719 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
297 generic and fewer than 11 brand-name prescriptions · $180,719 in drug cost · 25 antibiotic prescriptions to 14 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Mesalamine | 26 | $14,062 | $541 |
| Linzess | 12 | $8,439 | $703 |
| Gavilyte-C | 99 | $2,252 | $23 |
| Lubiprostone | 14 | $1,681 | $120 |
| Sulfasalazine | 11 | $596 | $54 |
See all 8 drugs
| Mesalamine | 26 | $14,062 | $541 |
| Linzess | 12 | $8,439 | $703 |
| Gavilyte-C | 99 | $2,252 | $23 |
| Lubiprostone | 14 | $1,681 | $120 |
| Sulfasalazine | 11 | $596 | $54 |
| Pantoprazole | 37 | $525 | $14 |
| Omeprazole | 49 | $465 | $9 |
| Famotidine | 19 | $208 | $11 |
Year by year
| 2024 | 376 | 209 | None | None | $180,719 |
| 2023 | 355 | 208 | None | None | $181,693 |
| 2022 | 406 | 230 | None | None | $128,173 |
| 2021 | 369 | 207 | 0% (0) | None | $103,072 |
| 2020 | 334 | 158 | None | None | $81,812 |
| 2019 | 383 | 212 | 0% (0) | 20% | $97,608 |
| 2018 | 448 | 260 | 0% (0) | None | $104,554 |
| 2017 | 447 | 248 | 0% (0) | None | $105,498 |
| 2016 | 478 | 275 | 0% (0) | None | $116,262 |
| 2015 | 426 | 224 | 0% (0) | None | $105,950 |
| 2014 | 582 | 344 | 0% (0) | 24% | $113,852 |
| 2013 | 487 | 285 | 0% (0) | 16% | $88,566 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 6 drugs
| Lialda | 16 | $9,338 | $584 |
| Gavilyte-C | 117 | $2,449 | $21 |
| Pantoprazole | 33 | $536 | $16 |
| Omeprazole | 50 | $481 | $10 |
| Famotidine | 18 | $232 | $13 |
| Dicyclomine | 11 | $118 | $11 |
2022: 8 drugs
| Lialda | 19 | $10,408 | $548 |
| Linzess | 16 | $8,803 | $550 |
| Gavilyte-C | 129 | $2,237 | $17 |
| Pantoprazole | 40 | $686 | $17 |
| Sulfasalazine | 12 | $527 | $44 |
| Famotidine | 30 | $437 | $15 |
| Omeprazole | 47 | $436 | $9 |
| Peg-3350 and Electrolytes | 20 | $398 | $20 |
2021: 6 drugs
| Gavilyte-C | 78 | $1,170 | $15 |
| Peg-3350 and Electrolytes | 35 | $727 | $21 |
| Pantoprazole | 35 | $650 | $19 |
| Omeprazole | 37 | $568 | $15 |
| Famotidine | 37 | $314 | $8 |
| Metronidazole | 11 | $103 | $9 |
2020: 4 drugs
| Gavilyte-C | 71 | $1,281 | $18 |
| Omeprazole | 45 | $870 | $19 |
| Pantoprazole | 28 | $475 | $17 |
| Famotidine | 34 | $248 | $7 |
2019: 5 drugs
| Humira | 11 | $44,621 | $4,056 |
| Opium Tincture | 14 | $5,671 | $405 |
| Gavilyte-C | 137 | $4,880 | $36 |
| Omeprazole | 52 | $1,081 | $21 |
| Pantoprazole | 29 | $604 | $21 |
2018: 6 drugs
| Humira | 12 | $46,782 | $3,899 |
| Lialda | 13 | $15,123 | $1,163 |
| Gavilyte-C | 107 | $4,029 | $38 |
| Peg 3350-Electrolyte | 74 | $2,741 | $37 |
| Omeprazole | 66 | $1,536 | $23 |
| Pantoprazole | 46 | $1,148 | $25 |
2017: 7 drugs
| Lialda | 12 | $14,921 | $1,243 |
| Linzess | 12 | $4,658 | $388 |
| Gavilyte-C | 166 | $2,834 | $17 |
| Omeprazole | 77 | $2,138 | $28 |
| Pantoprazole | 47 | $1,393 | $30 |
| Propranolol | 12 | $635 | $53 |
| Ranitidine | 13 | $301 | $23 |
2016: 8 drugs
| Lialda | 15 | $17,142 | $1,143 |
| Gavilyte-C | 207 | $3,519 | $17 |
| Omeprazole | 66 | $2,813 | $43 |
| Propranolol | 12 | $750 | $62 |
| Cholestyramine | 11 | $740 | $67 |
| Pantoprazole | 17 | $605 | $36 |
| Ranitidine | 14 | $256 | $18 |
| Spironolactone | 11 | $196 | $18 |
2015: 9 drugs
| Entecavir | 11 | $17,065 | $1,551 |
| Lialda | 14 | $15,014 | $1,072 |
| Budesonide Ec | 13 | $13,025 | $1,002 |
| Omeprazole | 70 | $3,542 | $51 |
| Gavilyte-C | 144 | $2,472 | $17 |
| Pantoprazole | 40 | $1,470 | $37 |
| Sucralfate | 11 | $1,398 | $127 |
| Cholestyramine | 14 | $965 | $69 |
| Famotidine | 11 | $212 | $19 |
2014: 12 drugs
| Lialda | 25 | $26,199 | $1,048 |
| Budesonide Ec | 19 | $18,725 | $986 |
| Pentasa | 11 | $9,947 | $904 |
| Omeprazole | 75 | $3,449 | $46 |
| Gavilyte-C | 192 | $3,257 | $17 |
| Pantoprazole | 58 | $1,961 | $34 |
| Sucralfate | 15 | $1,837 | $122 |
| Cholestyramine | 14 | $988 | $71 |
| Peg 3350-Electrolyte | 47 | $791 | $17 |
| Ranitidine | 13 | $268 | $21 |
| Gavilyte-G | 11 | $231 | $21 |
| Famotidine | 11 | $172 | $16 |
2013: 7 drugs
| Budesonide Ec | 17 | $22,708 | $1,336 |
| Lialda | 15 | $12,263 | $818 |
| Omeprazole | 86 | $4,121 | $48 |
| Gavilyte-C | 176 | $3,015 | $17 |
| Pantoprazole | 60 | $2,414 | $40 |
| Sucralfate | 13 | $1,457 | $112 |
| Famotidine | 11 | $183 | $17 |
Money from drug and device companies
$116 in 2024
| 2024 | 3 | 3 | None | $116 |
| 2023 | 1 | 3 | None | $407 |
| 2019 | 1 | 1 | None | $60 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Kestra Medical Technology Services | Assure Wcd | $79 | 1 payment
|
| ShockWave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $22 | 1 payment
|
| Abbott Laboratories | Jot Dx | $15 | 1 payment
|
See all 3 published payments
| Kestra Medical Technology Services | Meals · 2024-07-18 | Assure Wcd | $79 |
| Abbott Laboratories | Meals · 2024-07-11 | Jot Dx | $15 |
| ShockWave Medical | Meals · 2024-06-19 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $22 |
See earlier years (2023, 2019)
2023: $407
| Abbott Laboratories | Ensite | $407 | 3 payments
|
2019: $60
| Conmed | Conmed Biliary | $60 | 1 payment
|
Professional record
- NPI
- 1871757153
- Licence
- CA A93986California A93986: Current · expires 2027-10-31
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X)
- Mailing address
- 1021 W Riverside Way, San Jose, CA, 95129
- NPI first listed
- 2008-07-15
- NPI last updated
- 2021-12-13
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.